disease characteristic
Item
disease characteristics:
boolean
C0599878 (UMLS CUI [1])
Mantle cell lymphoma
Item
histologically confirmed mantle cell lymphoma
boolean
C0334634 (UMLS CUI [1])
TNM clinical staging
Item
all stages allowed
boolean
C3258246 (UMLS CUI [1])
Disease untreated
Item
previously untreated disease
boolean
C0012634 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Measurable Disease | Evaluable Disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
Central Nervous System Involvement
Item
no cns involvement
boolean
C4050309 (UMLS CUI [1])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy > 6 months
boolean
C0023671 (UMLS CUI [1])
Serum total bilirubin measurement
Item
bilirubin < 3 mg/dl
boolean
C1278039 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Lymphomatous nodal involvement
Item
sgot and/or sgpt < 2.5 times upper limit of normal (unless due to lymphomatous involvement)
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C0441949 (UMLS CUI [3])
Creatinine measurement, serum
Item
creatinine < 1.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Fertility Contraceptive methods | Fertility Contraception, Barrier | Thalidomide
Item
fertile patients must use effective double-method contraception during and for ≥ 4 weeks after completion of study treatment (if receiving thalidomide)
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0015895 (UMLS CUI [2,1])
C0004764 (UMLS CUI [2,2])
C0039736 (UMLS CUI [3])
Malignant Neoplasms | Carcinoma in situ of uterine cervix | Basal cell carcinoma
Item
no other concurrent active malignancies, except for in situ carcinoma of the cervix or basal cell carcinoma of the skin
boolean
C0006826 (UMLS CUI [1])
C0851140 (UMLS CUI [2])
C0007117 (UMLS CUI [3])
Heart failure | New York Heart Association Classification
Item
grade 3-4 cardiac failure
boolean
C0018801 (UMLS CUI [1])
C1275491 (UMLS CUI [2])
Left ventricular ejection fraction
Item
lvef that is less than ≥ 50%
boolean
C0428772 (UMLS CUI [1])
Condition Excludes Protocol Compliance
Item
psychological, familial, sociological, or geographical conditions that would preclude study compliance
boolean
C0348080 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
HIV | Acquired Immunodeficiency Syndrome
Item
known history of hiv or aids
boolean
C0019682 (UMLS CUI [1])
C0001175 (UMLS CUI [2])
Hepatitis | Hepatitis B
Item
hepatitis or hepatitis b virus infection
boolean
C0019158 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
Prior Therapy
Item
prior concurrent therapy:
boolean
C1514463 (UMLS CUI [1])
Prior Chemotherapy Mantle cell lymphoma | Prior Immunotherapy Mantle cell lymphoma | prior radiation therapy Mantle cell lymphoma
Item
any prior chemotherapy, immunotherapy, or radiotherapy for this lymphoma
boolean
C1514457 (UMLS CUI [1,1])
C0334634 (UMLS CUI [1,2])
C1514461 (UMLS CUI [2,1])
C0334634 (UMLS CUI [2,2])
C0279134 (UMLS CUI [3,1])
C0334634 (UMLS CUI [3,2])